Sign in

CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Aura Biosciences, Inc.

Sign in to watch
Ticker
AURA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
320271970
Phone
(617)500-8864
Business address
80 GUEST STREET, BOSTON, MA, 02135
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Other events
  3. 8-K Event Shareholder vote results
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Grant or award Director acquired 30,000 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change
  8. 4 Grant or award See Remarks acquired 14,858 shares (grant or award)
  9. DEF 14A Proxy Proxy Statement
  10. PRE 14A Proxy Proxy Statement (Preliminary)
  11. 144 Insider Sale of Securities
  12. 4 Open-market sale See Remarks sold 12,824 shares at $6.42 ($82,330)
  13. 4 Grant or award Director acquired 15,000 shares (grant or award)
  14. 4 Grant or award Director acquired 15,000 shares (grant or award)
  15. 4 Grant or award Director acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 15,000 shares (grant or award)
  17. 8-K Event Shareholder vote results
  18. 4 Grant or award See Remarks acquired 1,153,962 shares (grant or award)
  19. S-8 Other Securities Offered to Employees in Benefit Plans
  20. SCHEDULE 13G Stake Statement of Beneficial Ownership

Page 2 of 20 · 383 filings